Chardan Capital Markets

Chardan Capital Markets is a prominent independent, full-service global investment bank headquartered in New York City. Founded in 2002, the firm specializes in SPACs (Special Purpose Acquisition Companies), healthcare, and disruptive innovation. It provides comprehensive financial services to corporate and institutional clients worldwide and is recognized for its significant contributions to the SPAC market, having participated in over 120 SPAC Initial Public Offerings (IPOs) with a total transaction value exceeding $15 billion, alongside 51 business combination transactions worth over $23 billion. As a registered broker-dealer with the U.S. Securities and Exchange Commission, Chardan is also a member of FINRA, SIPC, and NASDAQ.

Core Specializations and Services

• Healthcare and Biotech: Chardan offers strategic advisory services and facilitates capital market access for healthcare growth initiatives, leveraging its deep expertise in the sector.

• SPACs: Chardan has consistently led the market with co-sponsored SPAC transactions exceeding $1.4 billion.

• Disruptive Innovation: The firm targets transformational opportunities in emerging growth sectors, aiming for industry and societal advancements.

• Investment Banking: Comprehensive offerings include advisory services for mergers and acquisitions, equity, and debt financing.

Leadership Team

• Steven Urbach: Co-Founder and CEO, steering the strategic direction of Chardan's operations.

• Jonas Grossman: President, leading global capital markets initiatives.

• Kerry Propper: Co-Founder and Executive Chairman, also serving as a Managing Partner at ATW Partners.

• Scott Blakeman: Partner, Head of Equity Trading.

• Shai Gerson: Partner, Capital Markets.

• George Kaufman: Partner, Head of Investment Banking.

• Emily Levine: Chief Commercial Officer.

• Ron Glickman: Managing Director, Business Development.

• David Lederman: Managing Director, Capital Markets.

• Alex Weil: Managing Director, Co-Head of FinTech Investment Banking.

• Caitlin Doyle: Chief Human Resources Officer.

Strategic Vision

Chardan’s strategic focus lies in identifying enduring opportunities with lasting societal impact. The firm is committed to rigorous and insightful research to identify and capitalize on emerging growth sectors, supporting its goal to drive industries forward globally through performance excellence and intellectual honesty.

Key Locations

• New York Headquarters: One Pennsylvania Plaza, Suite 4800, New York, NY 10119

• Greenwich, CT Office: One East Putnam Ave, 4th Fl., Greenwich, CT 06830

For communication, Chardan can be reached through:

• Phone: +1 646-465-9000

• Email: info@chardan.com

Competitive Analysis

Financial Overview

Chardan generates an annual revenue of approximately $35 million and operates with a team of around 84 employees, signifying a focused yet impactful presence in the investment banking domain.

Key Competitors

• Needham & Company: Known for its focus on growth companies, Needham offers services in public/private financing, M&A, equity research, and institutional sales and trading. It prides itself on long-term value creation and strategic advisory rooted in integrity.

• Young America Capital: This rapidly-growing firm specializes in capital raising, M&A, and financial advisory for the middle market and family businesses, focusing on sectors like telecommunications, healthcare, and clean technology.

• ABG Sundal Collier: A Nordic investment bank offering corporate advisory, corporate financing, and securities research, emphasizing corporate governance and sustainability with a strong regional presence.

Strategic Positioning

Chardan’s specialization in SPACs and healthcare positions it uniquely within the investment landscape, particularly advantageous amid rapid innovation and regulatory shifts. The firm’s expertise allows it to tailor financial products and advisory services to meet the demands of disruptive innovation, distinguishing it from other firms with more generalized offerings. This niche positioning strengthens Chardan’s ability to connect with clients interested in leveraging modern investment vehicles and navigating the evolving healthcare sector, aiding in client acquisition, retention, and sustained growth.